Karuna Therapeutics Inc - ESG Rating & Company Profile powered by AI
If you work at Karuna Therapeutics Inc and you wish to use your Sustainability rating, please contact us. Detailed ESG analysis of Karuna Therapeutics Inc can be accessed by registering for free. This report of Karuna Therapeutics Inc leverages data points from across the internet and also from public filings by Karuna Therapeutics Inc.
Karuna Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.1; made up of an environmental score of 1.3, social score of 2.3 and governance score of 2.7.
2.1
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1551 | Voyager Life PLC | 2.2 | Medium |
| 1551 | Source Natural Foods and Herbal Supplements Ltd | 2.2 | Medium |
| 1571 | Karuna Therapeutics Inc | 2.1 | Medium |
| 1571 | Cerevel Therapeutics Holdings Inc | 2.1 | Medium |
| 1571 | Charlotte's Web Holdings Inc | 2.1 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Karuna Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Karuna Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Karuna Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Karuna Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Karuna Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Karuna Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Karuna Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Karuna Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Karuna Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Karuna Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Karuna Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Karuna Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Karuna Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Karuna Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Karuna Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Karuna Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Karuna Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Karuna Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Karuna Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Karuna Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Karuna Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Karuna Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Karuna Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Karuna Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Karuna Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Karuna Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Karuna Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Karuna Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Karuna Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Karuna Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Karuna Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Karuna Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Karuna Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Karuna Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Karuna Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Karuna Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Karuna Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients with schizophrenia; and for the treatment of central nervous system disorders, such as negative and cognitive symptoms of schizophrenia and psychosis, as well as for the treatment of dementia-related psychosis. The company also focuses on developing other muscarinic-targeted drug candidates. Karuna Therapeutics, Inc. has a license agreement with Eli Lilly and Company, and Zai Lab (Shanghai) Co., Ltd; patent license agreement with PureTech Health LLC; and drug discovery partnership with Charles River Laboratories, as well as drug discovery collaboration with PsychoGenics, Inc. The company was formerly known as Karuna Pharmaceuticals, Inc. and changed its name to Karuna Therapeutics, Inc. in March 2019. Karuna Therapeutics, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.